Study: Semaglutide drug promotes weight loss in patients with type 2 diabetes

By | March 3, 2021
Patients with type 2 diabetes that were treated with a weekly injection of the breakthrough drug Semaglutide were able to achieve an average weight loss of nearly 10kg, according to a new study published in The Lancet today.